Hypotension Prediction Index (HPI) SMART-BP Trial
Hypotension Prediction Index (HPI) Software Guided Hemodynamic Management for Noncardiac Surgery Patients - Blood Pressure Trial (National PI: Kamal Maheshwari, MD, MPH)
Sponsor: Edwards Lifesciences
Terminated
Halted prematurely; voluntarily discontinuation of trial as study specific protocol not followed during data collection
Other terminated trials from Edwards Lifesciences
Listed as NCT05105477, this NA trial focuses on Moderate to High-risk Noncardiac Surgery and remains terminated or withdrawn. Sponsored by Edwards Lifesciences, it has been updated 7 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2024 — Jul 2024 [monthly]
Terminated NA
-
Mar 2023 — Apr 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2022 — Mar 2023 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Feb 2022 — Jun 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .